May 12, 2021 / 07:30PM GMT
Jason Matthew Gerberry - BofA Securities, Research Division - MD in US Equity Research
Good day, everybody. Thank you for joining the Bank of America Annual Healthcare Conference. My name is Jason Gerberry. I'm one of the biotech analysts at BofA. And I am pleased to be introducing our next company presenter, Ionis, and CFO, Beth Hougen. So Beth, thanks so much for joining us, first off, at the conference today.
Elizabeth L. Hougen - Ionis Pharmaceuticals, Inc. - Executive VP of Finance & CFO
Thank you. Thanks for having us. We're pleased to be here.
Questions and Answers:
Jason Matthew Gerberry - BofA Securities, Research Division - MD in US Equity ResearchGreat. Great. So look, Ionis is one of the premier companies in the RNA space in terms of developing a platform, ASO platform. Maybe can you just set the stage in terms of how the company's capital allocation strategy and just broader strategy has changed in the last few years? The Sobi partnership is one example of a change. There's been messaging
Trustpilot
